Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.

*Required

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com

News

13/11/2024

Concept Life Sciences Welcomes Chris Yarnold as Director Of Medicinal Chemistry

We are pleased to welcome Chris Yarnold as our new Director of Medicinal Chemistry. In this role, Chris will oversee scientific operations and project management within our organization.

He brings over 20 years of experience in integrated drug discovery, medicinal chemistry, and project leadership, with expertise honed at Dalriada Drug Discovery and Evotec (UK) Ltd.

Most recently, Chris served as Director of Discovery Chemistry at Dalriada, where he led numerous drug discovery projects across a range of therapeutic areas and contributed to business development initiatives. Prior to that, he held the role of Group Leader, Discovery Chemistry, at Evotec.

Chris has extensive project leadership experience in major disease areas, including Cardiovascular, CNS, Oncology, and Metabolic diseases. Additionally, he has managed projects targeting anti-infectives, iron overload diseases, and anti-thrombotic therapies. His expertise spans hit finding, Hit-to-Lead, and Lead Optimization phases, where he contributed to the identification of three clinical candidates. Chris has successfully targeted enzymes, GPCRs, and transporters with small molecules and has a strong track record of team leadership, fostering the development of chemists to reach their full potential.

Chris holds a BSc (Joint Hons) in Chemistry and Biology and a Ph.D. from King’s College London. He also completed postdoctoral research with Professor Walter Szarek at Queen’s University, Kingston, Canada, and with Professor Chris McGuigan at the Welsh School of Pharmacy, Cardiff.

Dr Thomas Pesnot, Director of Drug Discovery Services, shared:

“We are delighted to welcome Chris to the team. His addition is a strategic step in strengthening our medicinal chemistry capabilities, and his leadership will be instrumental in driving innovative projects and advancing high-quality drug candidates.”

Upcoming Events Schedule
Search
Clear
Country
Clear
Month
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 of 100
No results found.
There are no results with this criteria. Try changing your search.
News and Expert Knowledge
Search
Clear
Type
Clear
Relevant Service Line
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 of 100
No results found.
There are no results with this criteria. Try changing your search.